Month: June 2021

GENEVA, June 03, 2021 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, today announced that Solar Resources Holding Sàrl and Etrion Japan K.K., wholly-owned subsidiaries of the Company, have entered into agreements (the “Transfer Agreements)” to sell their interests in the Company’s 9.5 MW Misawa operating solar energy project to a Japanese company, GK Misawa Solar, for an aggregate net purchase price of approximately JPY 1.6 billion (or USD 14.6 million), subject to certain adjustments at closing. Completion of the sale of the 9.5 MW Misawa project pursuant to the Transfer Agreements is subject to certain conditions precedent including all necessary regulatory and third-party approvals, as well as the buyer being satisfied with the Company’s recovery plan...

TORONTO, Ontario and BROSSARD, Québec, June 03, 2021 (GLOBE NEWSWIRE) — Bitfarms Ltd. (“Bitfarms”, or the “Company”) (TSXV: BITF // OTC:BFARF), today announces the appointment of Jeffrey Lucas as Chief Financial Officer, effective June 14, 2021, as well as two management promotions. Mr. Lucas brings to Bitfarms extensive international financial and operational experience with public companies listed on the NYSE and Nasdaq. He will be responsible for the oversight of the finance, accounting, and reporting functions with the mandate to raise capital, enhance our corporate communications, expand our investor relations activities, increase analyst coverage, and support and integrate acquisitions as part of building a higher level of financial and operational excellence throughout the Company. Prior to his corporate roles, Mr. Lucas...

New Brand Supports Strategic Corporate Vision as “One Medivolve” Built for Transformation; Solidifying Mission to Address Gaps in the Nation’s Health System TORONTO, June 03, 2021 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare technology and services company, today announced a rebrand of the company to support its evolution from investment insurer to health-tech disruptor. The new visual identity also unites all assets and subsidiaries under a single Medivolve brand umbrella, further cementing the company’s move toward a powerful, singular mission to create healthier lives. The new branding reflects the long-term strategic vision of Medivolve’s newly appointed CEO, David Preiner, underscored by momentum from a series of recent acquisitions and corporate milestones. “Medivolve’s rebranding...

PHOENIX, June 03, 2021 (GLOBE NEWSWIRE) — Leslie’s, Inc. (“Leslie’s” or the “Company”; NASDAQ: LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry announced that Mike Egeck, Chief Executive Officer, and Steve Weddell, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the William Blair Annual Growth Stock Conference today, Thursday, June 3, 2021 at 10:00 am Central Time. The Company is also raising its guidance for the full year Fiscal 2021. Mike Egeck, Chief Executive Officer, commented on recent results saying, “We are very pleased with our third quarter performance to date which has exceeded our expectations for both sales and earnings. We’ve experienced a strong start to pool season 2021 and key drivers of our outperformance...

High rate of complete responses in RP1 skin cancer cohorts underscore the potential for profound patient benefit and supports the ongoing registration directed development programs RP2 data confirms the signal with RP1 in anti-PD1 failed melanoma, uveal melanoma and in treating patients whose cancer has metastasized to the liver Announces plans to initiate broad Phase 2 development of RP2 and/or RP3 in tumor types that commonly metastasize to the liver Virtual investor event to be held at 8:00 am ET WOBURN, Mass., June 03, 2021 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic® platform, today announced updated interim data from the Phase 2 skin cancer cohorts combining RP1 (vusolimogene oderparepvec) with Opdivo®* (nivolumab)...

TORONTO, June 03, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce that dried flower grown at its Niagara greenhouse facility has been successfully exported to Germany. Gaining access to Europe’s most mature legal cannabis market is an important breakthrough for Aleafia Health, with fulfilment of successive purchase orders to Germany currently underway. Germany represents the second major medical cannabis market to which the Company has successfully completed exports. Import and export permits have been secured for two additional orders to Australia, with the shipments expected to occur in June. “The investments we’ve made in the highest levels of global regulatory compliance are just now beginning...

MSP-1014 selected based on head-to-head comparison to psilocybin and its active metabolite psilocin MSP-1014 showed greater safety and efficacy in in vitro and in vivo preclinical models Cost effective for cGMP manufacturing and IND-enabling studies TORONTO, June 03, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company“), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today announced that it has selected its lead clinical candidate, MSP-1014, a differentiated psilocybin-based compound from its Family 1 of novel, patent-pending psychedelic compounds to move forward into current good manufacturing practice...

VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) announces it has initiated a new clinical research program for pancreatic cancer (PC) and NP-120 (Ifenprodil). Ifenprodil demonstrated a significant anti-tumour effect in a PC animal model which was reported in a paper published in the Dove Press Journal, Clinical Pharmacology: Advances and Applications. The research paper concluded that Ifenprodil significantly and rapidly reduced the average solid tumour size by approximately 50% by day three and remained stable while on treatment in a murine model of PC. The average tumour size in the untreated group doubled during the same period. PC is an orphan disease and has a five-year survival rate of 7.9%. This means that...

Shanghai, China, June 03, 2021 (GLOBE NEWSWIRE) — Jowell Global Ltd. (“JWEL” or the “Company”) (NASDAQ: JWEL), a company which operates one of the leading cosmetics, health and nutritional supplements and household products e-commerce platforms – Juhao Mall in China, today announced that it has presented Juhao Best Choice Store at 2021 China (Changshu) International Business Equipment Exposition to showcase its new innovative online platform plus offline community group-buying retail store business model. Mr. Zhiwei Xu, CEO and Chairman of the Company introduced Juhao Best Choice Store’s marketing and sales model to officials from Changshu local governments, national supply chain association, national commerce and enterprise association and national grocery products for daily use marketing society during the exposition,...

MONTREAL, June 03, 2021 (GLOBE NEWSWIRE) — Saputo Inc. (“Saputo”) (TSX:SAP) will release its fiscal 2021 fourth quarter financial results on Thursday, June 3, 2021. A webcast and conference call will be held the same day to discuss the financial results as well as to present Saputo’s new global strategic plan and overarching growth strategy.Start time: 1:30 p.m. (Eastern Time)Duration: approximately 2 hoursWebcast (recommended): https://www.gowebcasting.com/11294Please note, there will be a visual element to the speakers’ presentation.Participants are encouraged to join the webcast for full access to the content.Conference line (audio only): 1-800-785-6502Please dial-in 10 minutes prior to the start time.The webcast will be structured as follows:Remarks on the fiscal 2021 fourth quarter financial results, followed...